For decades, traditional adrenaline auto-injectors (AAIs) have been the only available treatment for anaphylaxis—a life-threatening allergic reaction.1,2 Yet from today, the UK’s first needle-free emergency anaphylaxis treatment, the EURneffy® nasal adrenaline spray, is available on prescription.3 EURneffy® 2 mg nasal spray offers a…
the AI precision oncology company behind the Polaris™ platform, today announced its selection for the Memorial Sloan Kettering (MSK) iHub Challenge 2025 Cohort program. This engagement will provide StratifAI with access to MSK’s extensive clinical datasets and the opportunity to…
Iksuda Therapeutics (Iksuda), the developer of class leading, antibody drug conjugates (ADCs), today announces the presentation of new data from its Phase 1 study of IKS014, a human epidermal growth factor receptor 2 (HER2)-directed ADC, in patients with advanced HER2+…
DATROWAY® Demonstrates Significant Survival Benefit Over Chemotherapy in First-Line Metastatic Triple-Negative Breast Cancer in TROPION-Breast02 Trial Positive results from the pivotal TROPION-Breast02 phase 3 trial have shown that DATROWAY® (datopotamab deruxtecan) delivers a statistically significant and clinically meaningful improvement in…
Delcath Systems, Inc. Reports Promising Phase 2 CHOPIN Trial Results for Liver-Dominant Metastatic Uveal Melanoma Delcath Systems, Inc. (NASDAQ: DCTH), a pioneering interventional oncology company focused on liver-directed therapies for primary and metastatic liver cancers, today announced the results of…
Researchers at General Atomics (GA) are playing a pivotal role in addressing one of the most complex and persistent challenges in the pursuit of fusion energy — sustaining and controlling the high-energy fuel that powers fusion reactions. In a landmark…
LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, has officially opened its new £20 million National Laboratories facility in Guildford, marking a significant investment in the UK’s scientific infrastructure. The facility reinforces the nation’s leadership in…
Ferring Pharmaceuticals has announced additional real-world evidence from a private urology practice evaluating the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC), specifically those with carcinoma in situ (CIS)…
Roquette, a global leader in plant-based ingredients and pharmaceutical excipients across the health, nutrition, and bioindustrial sectors, today announced the grand opening of its dedicated Health & Pharma Solutions Innovation Center in São Paulo, Brazil. The state-of-the-art facility marks a…
WISEcode™, the FoodTechAI™ company on a mission to deliver precision transparency in food, today announced the launch of WISEscore™, the first unified food score that merges ingredient quality and nutrient quality into a single, powerful metric. Now available in the…